Intco Medical Technology Co Ltd
SZSE:300677
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
20.71
45.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Operating Margin
Intco Medical Technology Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
26.2B CNY |
10%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
8T JPY |
30%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
31.7B CHF |
14%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
126.8B DKK |
28%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.7B USD |
16%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
45.9B CNY |
38%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP |
15%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD |
2%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.3B CHF |
28%
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
806.2B JPY |
25%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.1B USD |
11%
|
Intco Medical Technology Co Ltd
Glance View
In the bustling industrial landscape of China, Intco Medical Technology Co., Ltd. has carved a distinctive niche as a significant player in the production and global distribution of disposable medical products. Established in 2009, the company has orchestrated its growth strategy by focusing on the manufacture of essential medical consumables like gloves, face masks, thermal plastics, and non-woven products. Intco's operations are adeptly integrated, with facilities strategically located to optimize manufacturing efficiencies and logistical ease, facilitating swift distribution to over 100 countries. This strategic footprint ensures that products are rapidly dispatched to meet the ever-increasing demands of global healthcare markets. Driving the company’s financial engine is its diversified product portfolio, tailored to cater to a wide array of healthcare needs, from hospitals to individual consumers who prioritize personal health safety. The company monetizes its offerings through a robust sales network, leveraging both direct sales channels and partnerships with global distributors. While the COVID-19 pandemic played a role in increasing demand for personal protective equipment, Intco has sustained its profitability through a commitment to quality and innovation, continuously expanding its research and development initiatives. By maintaining a balance between high-volume production and stringent quality control, Intco Medical Technology thrives as a cornerstone in the healthcare supply chain, adeptly navigating the dynamics of a rapidly evolving industry.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Intco Medical Technology Co Ltd's most recent financial statements, the company has Operating Margin of 10.1%.